{"id":"comparator-varicella-zoster-virus-vaccine","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Injection site reactions (erythema, swelling, tenderness)"},{"rate":"10-15","effect":"Fever"},{"rate":"5-10","effect":"Rash"},{"rate":"5-10","effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The varicella zoster virus vaccine contains live attenuated virus that replicates in host cells, triggering both humoral (antibody) and cell-mediated immune responses. This primes the immune system to recognize and rapidly respond to natural VZV infection, preventing disease or reducing severity. The vaccine provides long-term protection through immunological memory.","oneSentence":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against varicella zoster virus, preventing chickenpox and herpes zoster infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:20.109Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of varicella (chickenpox)"},{"name":"Prevention of herpes zoster (shingles) and post-herpetic neuralgia"}]},"trialDetails":[{"nctId":"NCT07481604","phase":"PHASE2","title":"Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above","status":"NOT_YET_RECRUITING","sponsor":"CHA Vaccine Institute Co., Ltd.","startDate":"2026-04","conditions":"Herpes Zoster","enrollment":135},{"nctId":"NCT07400003","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine","status":"RECRUITING","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2026-01-06","conditions":"Herpes Zoster, mRNA Vaccine","enrollment":519},{"nctId":"NCT05304351","phase":"PHASE2","title":"Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"Curevo Inc","startDate":"2022-02-02","conditions":"Herpes Zoster, Shingles","enrollment":1516},{"nctId":"NCT03604406","phase":"PHASE2","title":"The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kevin Winthrop","startDate":"2014-05-08","conditions":"Herpes Zoster, Inflammatory Disease, Rheumatoid Arthritis","enrollment":154},{"nctId":"NCT06409494","phase":"PHASE1","title":"Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years","status":"ACTIVE_NOT_RECRUITING","sponsor":"EuBiologics Co.,Ltd","startDate":"2024-07-15","conditions":"Varicella Zoster Virus Infection, Herpes Zoster","enrollment":72},{"nctId":"NCT04016714","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-08-28","conditions":"Pneumococcal Infections","enrollment":1191},{"nctId":"NCT05130398","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, Gabon","status":"COMPLETED","sponsor":"Centre de Recherche Médicale de Lambaréné","startDate":"2021-04-09","conditions":"Ebola Virus Disease","enrollment":120},{"nctId":"NCT03375502","phase":"PHASE2, PHASE3","title":"A Study of MG1111 in Healthy Children","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2016-11-26","conditions":"Healthy Children","enrollment":814},{"nctId":"NCT00696709","phase":"PHASE1","title":"A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-12-12","conditions":"Herpes Zoster","enrollment":290},{"nctId":"NCT01341639","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)","status":"COMPLETED","sponsor":"MCM Vaccines B.V.","startDate":"2011-05-26","conditions":"Bacterial Infections, Virus Diseases","enrollment":1250},{"nctId":"NCT00326183","phase":"PHASE4","title":"Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-03-26","conditions":"Hepatitis A, Measles, Mumps","enrollment":1800},{"nctId":"NCT01527383","phase":"PHASE2","title":"A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-02-21","conditions":"Herpes Zoster","enrollment":354},{"nctId":"NCT00969436","phase":"PHASE3","title":"Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11-09","conditions":"Varicella, Rubella, Mumps","enrollment":450},{"nctId":"NCT00312858","phase":"PHASE4","title":"Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-04","conditions":"Hepatitis A Virus","enrollment":653},{"nctId":"NCT00822237","phase":"PHASE3","title":"Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-01","conditions":"Varicella","enrollment":598},{"nctId":"NCT00534248","phase":"PHASE3","title":"Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-10","conditions":"Shingles","enrollment":22439},{"nctId":"NCT00109343","phase":"PHASE3","title":"V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-03","conditions":"Measles, Mumps, Rubella","enrollment":1027},{"nctId":"NCT00985153","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2000-03","conditions":"Measles, Mumps, Rubella","enrollment":3927},{"nctId":"NCT00092391","phase":"PHASE3","title":"A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1999-02","conditions":"Measles, Mumps, Rubella","enrollment":1997},{"nctId":"NCT00092417","phase":"PHASE3","title":"Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2003-10","conditions":"Healthy","enrollment":695},{"nctId":"NCT00975507","phase":"PHASE3","title":"ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1998-03","conditions":"Measles, Mumps, Rubella","enrollment":480},{"nctId":"NCT00886613","phase":"PHASE1","title":"A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-03","conditions":"Herpes Zoster","enrollment":120},{"nctId":"NCT00231816","phase":"PHASE3","title":"A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-09","conditions":"Herpes Zoster","enrollment":763},{"nctId":"NCT00984295","phase":"PHASE3","title":"Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2000-06","conditions":"Measles, Mumps, Rubella","enrollment":1913},{"nctId":"NCT00985166","phase":"PHASE3","title":"A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2000-08","conditions":"Measles, Mumps, Rubella","enrollment":801},{"nctId":"NCT00986232","phase":"PHASE2","title":"ProQuad Dose Selection Study (V221-011)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"1999-04","conditions":"Measles, Mumps, Rubella","enrollment":1551},{"nctId":"NCT00130793","phase":"PHASE3","title":"A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-08","conditions":"Herpes Zoster","enrollment":368}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Comparator: Varicella Zoster Virus Vaccine","genericName":"Comparator: Varicella Zoster Virus Vaccine","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against varicella zoster virus, preventing chickenpox and herpes zoster infection. Used for Prevention of varicella (chickenpox), Prevention of herpes zoster (shingles) and post-herpetic neuralgia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}